Immune status following measles vaccination in infants and evaluation for the need of revaccination.

dc.contributor.authorDutta, A Ken_US
dc.contributor.authorSinghal, P Ken_US
dc.contributor.authorKhare, Sen_US
dc.contributor.authorKumari, Sen_US
dc.contributor.authorMathur, Ren_US
dc.contributor.authorMullick, D Nen_US
dc.date.accessioned1989-08-01en_US
dc.date.accessioned2009-05-27T05:54:44Z
dc.date.available1989-08-01en_US
dc.date.available2009-05-27T05:54:44Z
dc.date.issued1989-08-01en_US
dc.description.abstractIn this prospective study, immune status of children vaccinated in infancy was determined at age 12-18 months. In 200 children, preimmunization protective measles hemagglutination (HI) antibody titres (greater than or equal to 1:8) were present in 38.5% of children of 6-8 months, the frequency decreased to 17.6 and 14.3% in age groups 9-11 and 12-18 months, respectively followed by an increasing incidence of 52.5% in those more than 18 months of age. Paired measles HI titre was estimated in 56 children, the post vaccination sample was taken at age 12-18 months, 3-9 months after measles vaccination. Most of the children (98.0%), with no detectable antibody titre, had a protective titre. Again a significant number (p less than 0.001) of children aged 12-18 months had protective HI titres compared to non-vaccinated. These findings suggest that when vaccinated at 9-11 months in our country, there is no need for revaccination later.en_US
dc.identifier.citationDutta AK, Singhal PK, Khare S, Kumari S, Mathur R, Mullick DN. Immune status following measles vaccination in infants and evaluation for the need of revaccination. Indian Pediatrics. 1989 Aug; 26(8): 765-72en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/13874
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAntibodies, Viral --analysisen_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshDeveloping Countriesen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunization Scheduleen_US
dc.subject.meshIndiaen_US
dc.subject.meshInfanten_US
dc.subject.meshMeasles --prevention & controlen_US
dc.subject.meshMeasles Vaccine --administration & dosageen_US
dc.subject.meshMeasles virus --immunologyen_US
dc.subject.meshProspective Studiesen_US
dc.titleImmune status following measles vaccination in infants and evaluation for the need of revaccination.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: